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Abstracts / Urological Science 26 (2015) S50eS81S64Purpose: Azoospermia factors (AZF) are located on the long arm of Y
chromosome and has been divided into three regions (AZFa, AZFb, AZFc).
During homologous recombination of Y chromosome, deletions may
occurred in these regions. The AZFc region is particularly susceptible to
deletions because its structure composed of many palindromes. To date,
some deletions resulting in partial loss of AZFc region had been reported,
and their relationship with male infertility had been discussed. We pre-
sented the treatment outcome in our hospital among non-obstructive
azoospermia (NOA) patients with AZFc subdeletion.
Materials and Methods:We retrospectively enrolled and analyzed AZFc
subdeletion patients from 2008 to 2014. The b2/b4 (AZFc total deletion)
deletion cases were not included. Totally 95 patients were diagnosed
AZFc subdeletion during this period, and among them, 48 patients
were NOA. We recruited another 109 age-matched NOA patients
without AZF subdeletion as control group. The hormone proﬁle, sperm
retrieval rate, pregnancy rate were compared between these two
groups.
Results: Among the 157 NOA patients, 104 had received microdissection
testicular sperm extraction (micro-TESE). The sperm retrieval rate was
31.2% in NOA patients with AZFc subdeletion, compared with 27.8% in
control group. (p ¼ 0.718) The most frequent AZFc subdeletion is g1/g3
(n ¼ 23), followed by gr/gr (n ¼ 17). The sperm retrieval rate was 25% in gr/
gr deletion, 31.2% in g1/g3 deletion, and 50% in other AZFc subdeletions
(p ¼ 0.646).
The pregnancy rate was 18.8% in NOA patients with AZFc subdeletion,
compared with 12.5% in control group (p ¼ 0.439).
Conclusion: In our data from limited patients, the sperm retrieval rate
seems poorer in NOA patients with gr/gr deletion, but better in patient
with other not gr/gr AZFc subdeletion. Although gr/gr deletion is reported
as a risk factor in male infertility in Western population, further infor-
mation from more patients is still needed to conﬁrm its clinical value in
Tawainese population.NDP055:
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Purpose: Our previous studies based on a knockout mice model indicated
that SEPT12 proteins are critical for the terminal morphological formation
of sperm. SEPT12 mutations in men result in teratozospermia and oligo-
zospermia. In addition, the spermatozoa exhibit morphological defects of
the head and tail, premature chromosomal condensation, and nuclear
damage. However, the molecular functions of SEPT12 during spermato-
genesis remain unclear. To determine the molecular functions of SEPT12,
we designed and carried out the present study.
Materials and Methods: We applied a yeast 2-hybrid system to identify
SEPT12 interactors. The molecule-biological skills included the following
items: Yeast 2-hybrid screening and b-galactosidase assay, Reverse tran-
scription-PCR (RT-PCR), Preparation of human testicular spermatogenic
cells and spermatozoa, Immunoﬂuorescence assay, Cloning, Transfection,
and Coimmunoprecipitation assay.
Results: Seven proteins that interact with SEPT12 were identiﬁed: SEPT
family proteins (SEPT4 and SEPT6), nuclear or nuclear membrane pro-
teins (PRM2, SPAG4, and NDC1), and sperm-related structural proteins
(PCM1 and OBSL1). SPAG4; also known as SUN4 belongs to the SUN
family of proteins and acts as a linker protein between nucleoskeleton
and cytoskeleton proteins and localizes in the nuclear membrane. We
determined that SEPT12 interacts with SPAG4 in a male germ cell line
through coimmunoprecipitation. During human spermiogenesis, SEPT12
is colocalized with SPAG4 near the nuclear periphery in round sper-
matids and in the centrosome region in elongating spermatids.Furthermore, we observed that SEPT12/SPAG4/LAMINB1 formed com-
plexes and were coexpressed in the nuclear periphery of round sper-
matids. In addition, mutated SEPT12 screened from an infertile man
affected the integration of these nuclear envelope complexes through
coimmunoprecipitation.
Conclusion: SEPT12 interactors are active at various stages during human
spermiogenesis. One of the interactors, SPAG4, is critical for the formation
of the nuclear membrane of sperm and DNA integration in the differen-
tiation of male germ cells.Female Urology & Urodynamics
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Purpose: Interstitial cystitis/painful bladder syndrome is a pelvic pain
condition that has been reported to be associated with other regional and
systemic pain syndromes as Irritable bowel syndrome (IBS), ﬁbromyalgia
(FM), chronic fatigue syndrome (CFS), and depression. Some study
considered that mild IC/PBS at baseline was associated with a mild IC/PBS
endpoint and chronic fatigue syndrome (CFS), however, predicted a
moderate/severe IC/PBS endpoint. Recently, the result from MAPP study
showed systemic IC/BPS had more severe pain symptom than regional IC/
BPS. However, there is no objective ﬁnding regarding association be-
tween voiding diary, anesthetic bladder capacity during cystoscopic
hydrodistension and non-bladder conditions. The purpose of this study
was to examine association between functional, anesthetic bladder ca-
pacity and non-bladder conditions in a physician diagnosed of women
with IC/BPS.
Materials and Methods: This was a retrospective cross-sectional study. Of
175 female patients who were compatible with AUA/SUFU criteria
including unpleasant sensation (pain, pressure, discomfort) perceived to
be related to bladder with duration >6 weeks were included. All of IC/BPS
patients were assessed by cystoscopic hydrodistension and all of them
have different severity of glomerulations. These patients were assessed by
validated questionnaire including O'Leary-Sant Symptom (ICSI) and
Problem Index (ICPI) was used to objectify subjective symptoms. Pelvic
Pain and Urgency/Frequency (PUF) questionnaire and VAS pain and urgent
score were also completed. Validated voiding diary and anesthetic bladder
capacity during 2-minutes hydrodistension were also measured. All pa-
tients completed medical history questionnaire for non-bladder condition.
Symptomatic duration was also asked. We separated IC/BPS patients into
two groups: pure IC/BPS and IC/BPS with comorbid disease. These data
were analyzed using independent T test.
Results: Patient demographics show the average age being 41.9± 12.8. The
mean symptomatic duration is 8.97± 7.80 years. There is no association
between symptomatic duration and symptom, voiding diary parameter,
and anesthetic bladder capacity. There is no difference between ICSI, ICPI,
PUF, urgent score and comorbid disease. However, systemic IC/BPS showed
more severe pain perception than pure IC/BPS (6.00± 2.61 vs 4.90± 3.04,
P ¼ 0.02). According to validated voiding diary, the mean value of daytime
frequency, daytime average voided volume, nocturnal frequency, and
nocturnal average voided volume are 14.58± 6.91, 103.74± 61.9 ml,
3.92± 1.86, 101.96± 83.53 ml. Systemic IC/BPS showed more day-time
voiding volume than pure IC/BPS (120.38 ± 51.3ml vs 102.87± 63.1ml,
P ¼ 0.05). However, there is no signiﬁcant association between daytime,
night-time frequency and comorbid disease. During cystoscopic hydro-
distension, there is no difference between anesthetic bladder capacity and
comorbid disease.
Conclusion: Systemic IC/BPS showed more severe pain perception
than pure IC/BPS but not lower urinary tract symptoms. However, systemic
IC/BPS did not showed smaller anesthetic bladder capacity than pure IC/
BPS.
